← Back to Clinical Trials
Recruiting NCT05382962

NCT05382962 iCanCope With Post-Operative Pain (iCanCope PostOp)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05382962
Status Recruiting
Phase
Sponsor The Hospital for Sick Children
Condition Pain, Chronic
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2021-09-28
Primary Completion 2026-01-28

Eligibility & Interventions

Sex All sexes
Min Age 12 Years
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
iCanCope Post Op Application

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2021-09-28 with a primary completion date of 2026-01-28.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

There are few applications available in the community to help teenagers manage pain after surgery. The focus of this study is to better understand the pain experience of children after having surgery and to design a Smartphone app called "iCanCope with Post-Operative Pain" (iCanCope PostOp), to help children and parents to better manage pain at home after surgery. The app will help keep track of pain, provide information about the teenager's surgery and provides "in-the-moment" advice wherever and whenever the patient needs it.

Eligibility Criteria

Inclusion Criteria: 1. aged 12 to 18 years; 2. own a smartphone compatible with the iCanCope app (iOS or Android); 3. diagnosed with adolescent idiopathic scoliosis or pectus carinatum or pectus excavatum; 4. are able to speak and read English; and 5. scheduled to undergo scoliosis or minimally invasive pectus repair surgery. Exclusion Criteria: 1. significant cognitive impairment or other co-existing medical condition that could limit the ability to use the iCanCope app, as identified by their health care provider; 2. participated in a previous study of iCanCope PostOp; 3. a diagnosed chronic pain condition not related to the surgical condition; or

Contact & Investigator

Central Contact

Jennifer Stinson, RN, PhD

✉ jennifer.stinson@sickkids.ca

📞 416-813-7654

Principal Investigator

Jennifer Stinson, RN, PhD

PRINCIPAL INVESTIGATOR

The Hospital for Sick Children

Frequently Asked Questions

Who can join the NCT05382962 clinical trial?

This trial is open to participants of all sexes, aged 12 Years or older, up to 18 Years, studying Pain, Chronic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05382962 currently recruiting?

Yes, NCT05382962 is actively recruiting participants. Contact the research team at jennifer.stinson@sickkids.ca for enrollment information.

Where is the NCT05382962 trial being conducted?

This trial is being conducted at Boston, United States, Toronto, Canada.

Who is sponsoring the NCT05382962 clinical trial?

NCT05382962 is sponsored by The Hospital for Sick Children. The principal investigator is Jennifer Stinson, RN, PhD at The Hospital for Sick Children. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology